Batia Avni

Hebrew University of Jerusalem — Israel

Medicine · Health Sciences

23h-index2.5kcitations120works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(27), CAR-T cell therapy research(18), Multiple Myeloma Research and Treatments(16), Amyloidosis: Diagnosis, Treatment, Outcomes(15), Acute Myeloid Leukemia Research(14)

Publications120 total

Supplementary Table 1 from Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
2025Open Access
Supplementary Figures S1-S7 from Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
2025Open Access
Supplementary Data 1 from Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
2025Open Access
Prospective predictors of toxicity of BCMA‑directed CART therapy in multiple myeloma
Blood·2025
Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma
Blood·2025Open Access
BCMA-targeted CAR T-cell therapy in refractory autoimmune diseases: Initial Results from a Phase 1 clinical trial
Blood·2025Open Access
High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T)
Cancers·2025· 1 citedOpen Access
CD19 CAR T‐Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia
Journal of Cellular and Molecular Medicine·2025· 1 citedOpen Access
Outcomes of Etanercept Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease in Adult and Pediatric Patients: A Retrospective Single-Center Cohort Study
2025Open Access
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
Frontiers in Immunology·2025· 5 citedOpen Access
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
Frontiers in Immunology·2025· 2 citedOpen Access
Efficacy and Safety of Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis
Journal of Clinical Oncology·2024· 14 cited
Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study
Bone Marrow Transplantation·2024· 1 citedOpen Access
Efficacy and Safety of Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for the Treatment of Relapsed and Refractory AL Amyloidosis
Blood·2024· 2 citedOpen Access
CD19 CAR-T Cell Therapy Is Effective in Richter Transformation: A Multicenter Retrospective Analysis By the European Research Initiative on Chronic Lymphocytic Leukemia
Blood·2024· 3 citedOpen Access
Efficacy of HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma
Blood·2024· 3 citedOpen Access
Belumosudil Is Efficacious for the Management of Heavily Pretreated and Prolonged Chronic Graft-Versus-Host Disease: A Retrospective Multi-Center Real-World Study By the Israel Association for Bone Marrow Transplantation and Cellular Therapy
Blood·2024· 1 cited
OA-34 HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2024
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma
Blood Advances·2024· 10 citedOpen Access
Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis PA142 (#103)
2024· 3 cited
page 1 of 6Next →

Frequent Co-authors

Sigal Grisariu(27), Polina Stepensky(18), Moshe E. Gatt(11), Eran Zimran(10), Ron Ram(8), Eyal Lebel(8), Tsila Zuckerman(7), Shlomit Kfir‐Erenfeld(7), Nathalie Asherie(7), Miri Assayag(7), Marjorie Pick(6), Vladimir Vainstein(6), Irit Avivi(6), Shlomo Elias(6), Odelia Amit(5), Yaël C. Cohen(5), Cyrille J. Cohen(5), Reuven Or(4), Neta Goldschmidt(4), Liat Shargian(4)